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Abstract Glycosylasparaginase is a lysosomal amidase involved 
in the degradation of glycoproteins. Recombinant human 
glycosylasparaginase is capable of catalyzing the hydrolysis of 
the amino acid L-asparagine to L-aspartic acid and ammonia. For 
the hydrolysis of L-asparagine the Km is 3-4-fold higher and 
V-mnx 1/5 of that for glycoasparagines suggesting that the full 
catalytic potential of glycosylasparaginase is not used in the 
hydrolysis of the free amino acid. L-Asparagine competitively 
inhibits the hydrolysis of aspartylglucosamine indicating that 
both the amino acid and glycoasparagine are interacting with the 
same active site of the enzyme. The hydrolytic mechanism of L-
asparagine and glycoasparagines will be discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Bacterial and plant L-asparaginases catalyze the hydrolysis 
of L-asparagine (Asn) to L-aspartic acid (Asp) and ammonia 
(Reaction 1) [1]: 
L-asparagine + H20—> L-aspartic acid + NH 3 (1) 
Glycosylasparaginase (GA; aspartylglucosaminidase; 7V4-
(P-Af-acetyl-D-glucosaminyl)-L-asparaginase; EC 3.5.1.26), is 
a lysosomal amidase that hydrolyzes the N-glycosidic carbo-
hydrate-to-protein linkage (Af4-((5-Ar-acetyl-D-glucosaminyl)-L-
asparagine, aspartylglucosamine, GlcNAc-Asn) during the 
degradation of glycoproteins (Reaction 2) [2,3]. 
A'4-((3-A'-acctyl-D-glucosaminyl)-L-asparaginc+ 
H20—>L-asparticacid + L-amino-A'-acetylglucosamine (2) 
Plant and bacterial L-asparaginases and mammalian glyco-
sylasparaginases have many properties in common including 
marked sequence homology [4,5] and irreversible inhibition by 
an L-asparagine analogue, 5-diazo-4-oxo-L-norvaline (DONV) 
[4,6,7]. The structural properties of the substrate binding site 
of human glycosylasparaginase [8] led us to reconsider L-as-
paragine as a potential substrate for human glycosylasparagi-
nase. In the present study, we demonstrate that the hydrolysis 
of both L-asparagine and glycoasparagines is catalyzed by the 
recombinant human glycosylasparaginase. 
2. Materials and methods 
2.1. Materials 
GA was purified from an NIH-3T3 cell line overexpressing re-
combinant human placental GA [4,9], and the purification protocol 
involved caprylic acid precipitation, affinity chromatography, gel fil-
tration, hydrophobic interaction chromatography and anion exchange 
chromatography [4]. The fractions containing GA activity were 
pooled and the purity of this enzyme preparation was estimated to 
be over 90% on SDS-PAGE electrophoresis after silver staining and 
its glycosylasparaginase activity was 344 mU/mg towards AspAMC 
[10]. Total protein was determined using a Bio-Rad protein assay kit 
(Bio-Rad Laboratories, Hercules, CA, USA). Aspartylglucosamine, 
phenylisothiocyanate and carboxymethyl cysteine were products of 
Sigma Chemical Co., St. Louis, MO, USA. Asparagine and aspartic 
acid were purchased from E. Merck, Darmstadt, Germany. All the 
other reagents were of analytical grade and they were used without 
further purification. High-performance liquid chromatography 
(HPLC) was carried out with a Merck/Hitachi L-6200 liquid chroma-
tograph (Hitachi Ltd., Tokyo, Japan). The column was Spherisorb S3 
ODS2 (150X4.6 mm, i.d.) (Phase Separations Ltd., Deeside, UK). 
2.2. Enzyme assays 
Glycosylasparaginase assay was based on HPLC analysis of the 
reaction components GlcNAc-Asn, Asn and Asp after their phenyl-
isothiocyanate (PITC) derivatization [11,12]. Carboxymethyl cysteine 
(CmCys) was used as an internal standard. The kinetic and inhibition 
constants were determined at +22°C, and the incubation mixture con-
tained various amounts of GlcNAc-Asn and/or Asn, 0.8 mM CmCys 
and 60.8 uU GA (0.18 ug) in 50 mM sodium-potassium phosphate 
buffer, pH 7.5 in a total volume of 50 ul. 
The pH optimum of GA hydrolase activity was studied in Britton-
Robinson's universal buffer [4,13] over a pH range of 2.75-11.65 in 
intervals of 0.5 pH units. The incubation mixture consisted either of 
1.5 mM Asn, 0.8 mM CmCys and 125 uU of GA (0.36 ug) or 0.6 mM 
GlcNAc-Asn, 0.8 mM CmCys and 50 uU of GA (0.15 ug) in a total 
volume of 50 ul, and samples were taken for the HPLC assay usually 
at 0, 1, 2, 3, 4 and 6 h. The change in the substrate/internal standard 
ratio during the incubation was measured and compared to the stand-
ard curve. 
*Corresponding author. Fax: (358) (17) 173-179. 
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3. Results 
Authentic L-asparagine, L-aspartic acid and CmCys were 
individually derivatized and analyzed by H P L C . Fig. 1A dem-
onstrates that the compounds were well separated from one 
another. The chromatograms of samples removed at different 
time points (0, 6 and 22 h) from the reaction mixture initially 
containing Asn, CmCys and human recombinant G A are pre-
sented in Fig. 1B-D. The results demonstrate that L-aspara-
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Fig. 1. Characterization of components in the glycosylasparaginase-catalyzed reaction. HPLC chromatogram of a standard mixture containing 
equimolar amounts of Asp, CmCys and Asn (A), a reaction mixture containing 1.5 mM Asn after incubation at +37°C in the presence of gly-
cosylasparaginase for 0 h (B), 6 h (C) and 22 h (D). Asp, Asn and CmCys eluted at 8.6, 9.9 and 11.2 min, respectively. 
gine is hydrolyzed to L-aspartic acid by human glycosylaspar-
aginase, since this conversion was not observed in a blank 
reaction that was incubated 22 h in the absence of the enzyme 
(data not shown). In the conditions that were used to deter-
mine the kinetic constants for the hydrolysis of Asn, the re-
action was linear up to 480 min. The within-day variation of 
the enzyme assay, based on the substrate/internal standard 
ratio, was less than 7% (« = 10). The GA-catalyzed hydrolysis 
of both Asn and GlcNAc-Asn showed a wide pH-optimum 
range over pH 6-9 (Fig. 2). At pH 7.5, the Km and Kmax of 
human recombinant GA for Asn were 656 uM and 1.49 (xM 
min- 1 and for GlcNAc-Asn 208 |j,M and 7.23 uM min"1, 
respectively (Fig. 3). The maximal reaction velocity for the 
hydrolysis of Asn with GA was 21% of that obtained with 
the best natural substrate, GlcNAc-Asn. The presence of Asn 
in the reaction mixture competitively inhibited GlcNAc-Asn 
degradation by the enzyme with an inhibition constant K{ of 
454 uM (Fig. 4). 
These facts indicate that the same human enzyme degrades 
L-asparagine as well as a variety of glycoasparagines. The 
hydrolytic reactions catalyzed by human glycosylasparaginase 
are summarized in Fig. 5. 
4. Discussion 
Tanaka et al. [14] have shown that hog serum and kidney 
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Fig. 2. Effect of pH on the rate of GA-catalyzed hydrolysis of Asn 
(■) and GlcNAc-Asn (□). The rate of substrate loss is expressed as 
mU/mg protein. 
glycosylasparaginases have L-asparaginase activity whereas 
glycosylasparaginases from rat liver and kidney do not pos-
sess any activity towards the amino acid L-asparagine [15]. 
Glycosylasparaginases from Flavobacterium meningosepticum 
[16] and insect Spodoptera frugiperda [17] also show asparagi-
nase activity. This indicates that there is species variation in 
the substrate specificity of different glycosylasparaginases. 
While studying potential substrates of human GA by using 
a colorimetric assay of L-aspartic acid, the hydrolysis of L-
asparagine remained undetected [3]. The three dimensional 
structure of the active site of GA [8] led us to re-evaluate 
Asn as a potential substrate of human GA with improved 
analytical techniques. Both substrate Asn and product Asp 
in the reaction mixture were characterized and assayed with 
high-performance liquid chromatography. HPLC possesses 
several distinct advantages over the earlier used colorimetric 
assay including separation, identification and quantitation of 
the reaction components, and it is not subject to errors due to 
1/[S] (1/mM) 
Fig. 3. L-Asparagine and aspartylglucosamine as substrates for hu-
man glycosylasparaginase. The effect of Asn (o) and GlcNAc-Asn 
(•) concentration on the velocity of the glycosylasparaginase-cata-
lyzed reaction (inset) and the corresponding Lineweaver-Burk plots. 
c 
E 
o 
> 
1 0 
1/[S] (1/mM) 
Fig. 4. Determination of the inhibitor constant K[ for Asn with 
GlcNAc-Asn as a substrate. Various GlcNAc-Asn concentrations 
were incubated with 5 (n), 2 (■) and 0.5 mM (o) Asn and without 
Asn (•) A double-reciprocal plots of the reaction velocity versus 
GlcNAc-Asn concentration are shown. 
non-specific color formation which is a major problem with 
biological specimens. 
Human GA catalyzed the hydrolysis of L-asparagine to L-
aspartic acid and ammonia. The Km for the hydrolysis of Asn 
was 3^1-fold higher than that for glycoasparagines [3] whereas 
the Fmax was approximately 1/5 of that obtained for GlcNAc-
Asn. This suggests that the full catalytic potential of GA is 
not used in hydrolysis of Asn since the lack of glycosyl groups 
prevents effective interaction with the leaving group binding 
pocket of the enzyme. The pH optimum for GA-catalyzed 
hydrolysis of Asn was between 6 and 9 that is similar to 
that of rat [15,18], mouse [18], Spodoptera frugiperda [17] 
and human leukocyte [4] GA in the hydrolysis of GlcNAc-
Asn. Such a profile suggests that the enzyme could function 
outside the lysosomes although it is mainly located within 
these organelles. Asn competitively inhibited GlcNAc-Asn 
degradation by GA with an inhibitory constant (Ki = 454 
uM) close to the Km value of GA-catalyzed hydrolysis of 
GlcNAc-Asn (208 U.M) indicating that both compounds are 
interacting with the same active site of the enzyme. Thus in 
the GA-catalyzed hydrolysis of glycoasparagines [3,14], Asn is 
bound into the active site of the enzyme through its free oc-
amino and a-carboxyl groups. The N-atom attached to C4 of 
L-asparagine forms a hydrogen bond with Thr-206, which acts 
as a nucleophile [8,19]. The P-aspartyl intermediate is formed 
and subsequently L-aspartic acid and ammonia are released. 
E + H-Asn-OH 
Glyc -NH2 
1^ 
-NH, 
H20 
E + H-Asn(Glyc)-OH ^ - H-Asp(E)-OH . E + Asp-OH 
NH2OH 
r 
E + H-Asn(OH)-OH 
Fig. 5. A scheme for the reactions catalyzed by human glycosylas-
paraginase. H-Asn-OH, L-asparagine; Asp-OH, L-aspartic acid; 
NH3, ammonia; E, glycosylasparaginase; H-Asp(E)-OH, P-aspartyl 
enzyme intermediate; H-Asn(Glyc)-OH, glycoasparagine; Glyc-NH2, 
carbohydrate moiety with 1-amino-iV-acetylglucosamine; H-As-
n(OH)-OH, L-aspartic acid |3-hydroxamate [2,3,22]. 
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A deficient activity of G A causes a lysosomal storage dis-
ease, aspartylglycosammuria ( A G U ; McKusick 208400) (for 
review: [20]). The present results indicate that the potentially 
deficient degradation of Asn in A G U must be considered and 
investigated. The recently described mouse model for A G U 
[21] will be very helpful in these studies. 
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